Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Genes Medicine & Life Sciences
Androgens Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2019

Prostatic Neoplasms
Cell Survival


Garzotto, M., Alumkal, J., Higano, C., Hood, L., Lange, P., Plymate, S., Mostaghel, E., Vessella, R. L., Etzioni, R., Gleave, M., Yu, E. Y., Stanford, J. & Nelson, P.

National Institutes of Health


Project: Research projectSpecialized Center

Prostatic Neoplasms
Androgen Receptors

Research Output 2004 2017

  • 1591 Citations
  • 15 h-Index
  • 63 Article
  • 1 Review article
6 Citations

Analysis of circulating cell-free DnA identifies multiclonal heterogeneity of BRCA2 reversion mutations associated with resistance to PARP inhibitors

Quigley, D. , Alumkal, J. J. , Wyatt, A. W. , Kothari, V. , Foye, A. , Lloyd, P. , Aggarwal, R. , Kim, W. , Lu, E. , Schwartzman, J. , Beja, K. , Annala, M. , Das, R. , Diolaiti, M. , Pritchard, C. , Thomas, G. , Tomlins, S. , Knudsen, K. , Lord, C. J. , Ryan, C. & 5 others Youngren, J., Beer, T. M., Ashworth, A., Small, E. J. & Feng, F. Y. Sep 1 2017 In : Cancer Discovery. 7, 9, p. 999-1005 7 p.

Research output: Research - peer-reviewArticle

Prostatic Neoplasms
Poly(ADP-ribose) Polymerase Inhibitors
Recombinational DNA Repair

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide

Rathkopf, D. E. , Smith, M. R. , Ryan, C. J. , Berry, W. R. , Shore, N. D. , Liu, G. , Higano, C. S. , Alumkal, J. J. , Hauke, R. , Tutrone, R. F. , Saleh, M. , Maneval, E. C. , Thomas, S. , Ricci, D. S. , Yu, M. K. , de Boer, C. J. , Trinh, A. , Kheoh, T. , Bandekar, R. , Scher, H. I. & 1 others Antonarakis, E. S. 2017 In : Annals of Oncology. 28, 9, p. 2264-2271 8 p.

Research output: Research - peer-reviewArticle

Androgen Receptors
Prostatic Neoplasms
Prostatic Neoplasms
Odds Ratio

High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer

Friedlander, T. W. , Graff, J. N. , Zejnullahu, K. , Anantharaman, A. , Zhang, L. , Paz, R. , Premasekharan, G. , Russell, C. , Huang, Y. , Kim, W. , Aggarwal, R. R. , Lin, A. M. , Fong, L. , Alumkal, J. J. , Beer, T. M. , Sharifi, N. , Alyamani, M. , Dittamore, R. , Small, E. J. , Paris, P. L. & 1 others Ryan, C. J. 2017 (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Research - peer-reviewArticle

Prostatic Neoplasms
Abiraterone Acetate
Prostate-Specific Antigen
1 Citations

Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer

Armstrong, A. J., Halabi, S., Healy, P., Alumkal, J. J., Winters, C., Kephart, J., Bitting, R. L., Hobbs, C., Soleau, C. F., Beer, T. M., Slottke, R., Mundy, K., Yu, E. Y. & George, D. J. Aug 1 2017 In : European Journal of Cancer. 81, p. 228-236 9 p.

Research output: Research - peer-reviewArticle

Phosphatidylinositol 3-Kinases
Prostatic Neoplasms
MDV 3100